Efficiently Generating Japan-Specific Clinical Data to Streamline CDx Approval & Develop Efficacious, Tolerable Precision Therapies

• Generating Japan-relevant clinical data aligned with PMDA requirements for optimized CDx approval
• Coordinating CDx–drug development strategies to bring safe, effective precision therapies to patients in Japan

Speakers:

Tadayoshi Hashimoto

Physician

National Cancer Center Hospital East